JAZZ
Price
$121.16
Change
+$0.32 (+0.26%)
Updated
Jan 23, 02:19 PM (EDT)
Capitalization
7.31B
40 days until earnings call
SRPT
Price
$115.86
Change
-$0.23 (-0.20%)
Updated
Jan 23, 10:43 AM (EDT)
Capitalization
11.09B
40 days until earnings call
Ad is loading...

JAZZ vs SRPT

Header iconJAZZ vs SRPT Comparison
Open Charts JAZZ vs SRPTBanner chart's image
Jazz Pharmaceuticals
Price$121.16
Change+$0.32 (+0.26%)
Volume$100
Capitalization7.31B
Sarepta Therapeutics
Price$115.86
Change-$0.23 (-0.20%)
Volume$1.58K
Capitalization11.09B
JAZZ vs SRPT Comparison Chart
Loading...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAZZ vs. SRPT commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAZZ is a Hold and SRPT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (JAZZ: $120.84 vs. SRPT: $116.09)
Brand notoriety: JAZZ: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAZZ: 56% vs. SRPT: 71%
Market capitalization -- JAZZ: $7.31B vs. SRPT: $11.09B
JAZZ [@Biotechnology] is valued at $7.31B. SRPT’s [@Biotechnology] market capitalization is $11.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAZZ’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • JAZZ’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, JAZZ is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAZZ’s TA Score shows that 2 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • JAZZ’s TA Score: 2 bullish, 5 bearish.
  • SRPT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than JAZZ.

Price Growth

JAZZ (@Biotechnology) experienced а -1.95% price change this week, while SRPT (@Biotechnology) price change was -2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.65%. For the same industry, the average monthly price growth was +2.83%, and the average quarterly price growth was -1.43%.

Reported Earning Dates

JAZZ is expected to report earnings on May 13, 2025.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($11.1B) has a higher market cap than JAZZ($7.31B). SRPT has higher P/E ratio than JAZZ: SRPT (75.38) vs JAZZ (17.12). JAZZ YTD gains are higher at: -1.876 vs. SRPT (-4.523). JAZZ has higher annual earnings (EBITDA): 1.31B vs. SRPT (187M). JAZZ has more cash in the bank: 2.62B vs. SRPT (1.2B). SRPT has less debt than JAZZ: SRPT (1.4B) vs JAZZ (6.2B). JAZZ has higher revenues than SRPT: JAZZ (3.99B) vs SRPT (1.64B).
JAZZSRPTJAZZ / SRPT
Capitalization7.31B11.1B66%
EBITDA1.31B187M699%
Gain YTD-1.876-4.52341%
P/E Ratio17.1275.3823%
Revenue3.99B1.64B243%
Total Cash2.62B1.2B219%
Total Debt6.2B1.4B444%
FUNDAMENTALS RATINGS
JAZZ vs SRPT: Fundamental Ratings
JAZZ
SRPT
OUTLOOK RATING
1..100
223
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6262
PRICE GROWTH RATING
1..100
5076
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JAZZ's Valuation (62) in the Pharmaceuticals Other industry is in the same range as SRPT (82) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to SRPT’s over the last 12 months.

JAZZ's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SRPT (100) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to SRPT’s over the last 12 months.

JAZZ's SMR Rating (62) in the Pharmaceuticals Other industry is in the same range as SRPT (62) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to SRPT’s over the last 12 months.

JAZZ's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as SRPT (76) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's P/E Growth Rating (99) in the Biotechnology industry is in the same range as JAZZ (100) in the Pharmaceuticals Other industry. This means that SRPT’s stock grew similarly to JAZZ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JAZZSRPT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
70%
Bearish Trend 16 days ago
80%
Momentum
ODDS (%)
Bearish Trend 16 days ago
61%
Bullish Trend 16 days ago
76%
MACD
ODDS (%)
Bearish Trend 16 days ago
62%
Bullish Trend 16 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
59%
Bullish Trend 16 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
63%
Bearish Trend 16 days ago
72%
Advances
ODDS (%)
Bullish Trend 17 days ago
63%
Bullish Trend 18 days ago
75%
Declines
ODDS (%)
Bearish Trend 25 days ago
59%
Bearish Trend 25 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
63%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVMA59.58-0.06
-0.11%
Avantis Moderate Allocation ETF
PFFR18.69-0.03
-0.19%
InfraCap REIT Preferred ETF
RSPF74.71-0.26
-0.35%
Invesco S&P 500® Equal Weight Fincl ETF
IWD192.65-1.13
-0.58%
iShares Russell 1000 Value ETF
TSLY14.23-0.23
-1.59%
YieldMax TSLA Option Income Strategy ETF

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with TECX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-0.60%
TECX - SRPT
59%
Loosely correlated
+1.50%
GLMD - SRPT
51%
Loosely correlated
-0.70%
ALZN - SRPT
49%
Loosely correlated
-0.84%
XBIO - SRPT
48%
Loosely correlated
+0.00%
BMRN - SRPT
45%
Loosely correlated
-0.82%
More